Regulation of Angiogenesis and Angiogenic Factors by Cardiovascular Medications
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
2113-2117
Author(s):
Shin-ichiro Miura and Keijiro Saku
Visceral and Subcutaneous Adiposity: Are Both Potential Therapeutic Targets for Tackling the Metabolic Syndrome?
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
2169-2175
Author(s):
Amaia Rodriguez, Victoria Catalan, Javier Gomez-Ambrosi and Gema Fruhbeck
Homo obesus: A Metabotrophin-Deficient Species. Pharmacology and Nutrition Insight
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
2176-2179
Author(s):
G.N. Chaldakov, M. Fiore, A.B. Tonchev, D. Dimitrov, R. Pancheva, G. Rancic and L. Aloe
Non-Alcoholic Fatty Liver Disease in the Metabolic Syndrome
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
2193-2198
Author(s):
Giuseppe Palasciano, Antonio Moschetta, Vincenzo O. Palmieri, Ignazio Grattagliano, Gianluca Iacobellis and Piero Portincasa
Targeting the Liver in the Metabolic Syndrome: Evidence from Animal Models
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
2199-2207
Author(s):
Michele Petruzzelli, Giuseppe Lo Sasso, Piero Portincasa, Giuseppe Palasciano and Antonio Moschetta
Mechanistic Insights Into Diabetes Mellitus and Oxidative Stress
Journal:
Current Medicinal Chemistry
Volume:
14
Page:
1729-1738
Author(s):
Kenneth Maiese, Zhao Zhong Chong and Yan Chen Shang
Brittle Type 1 Diabetes Mellitus
Journal:
Current Medicinal Chemistry
Volume:
14
Page:
1739-1744
Author(s):
Federico Bertuzzi, Roberto Verzaro, Vincenzo Provenzano and Camillo Ricordi
Crucial Role of PDX-1 in Pancreas Development, β-Cell Differentiation, and Induction of Surrogate β-Cells
Journal:
Current Medicinal Chemistry
Volume:
14
Page:
1745-1752
Author(s):
Hideaki Kaneto, Takeshi Miyatsuka, Toshihiko Shiraiwa, Kaoru Yamamoto, Ken Kato, Yoshio Fujitani and Taka-aki Matsuoka
Editorial [Hot Topic: Stroke Prevention (Guest Editors: T. Tatlisumak, K. Rantanen and M. Fisher)]
Journal:
Current Drug Targets
Volume:
8
Page:
784-785
Author(s):
Turgut Tatlisumak, Kirsi Rantanen and Marc Fisher
Emerging Risk Factors for Cerebrovascular Disease
Journal:
Current Drug Targets
Volume:
8
Page:
802-816
Author(s):
Nina J. Solenski